Related Experiment Videos
IFN-gamma induces apoptosis in developing mast cells.
Meredith N Mann-Chandler1, Mohit Kashyap, Harry V Wright
1Department of Biology, Virginia Commonwealth University, Richmond, VA 23284-2012, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|August 24, 2005
Summary
Interferon-gamma (IFN-γ) induces programmed cell death (apoptosis) in mast cells, crucial for immune responses. This finding is vital for understanding inflammatory diseases and developing new treatments.
Area of Science:
- Immunology
- Cell Biology
Background:
- Mast cells are key players in allergic reactions and increasingly recognized in inflammatory conditions like arthritis and heart disease.
- Understanding mast cell development and survival is crucial for managing inflammatory diseases.
Purpose of the Study:
- To investigate the impact of Interferon-gamma (IFN-γ) on mast cell survival and development.
- To elucidate the molecular mechanisms underlying IFN-γ-induced mast cell apoptosis.
Main Methods:
- In vitro culture of bone marrow cells with IL-3 and stem cell factor, assessing apoptosis markers (subdiploid DNA, caspase activation, mitochondrial membrane potential).
- Utilizing knockout mice models (p53, Bax, SOCS-1, IFN-γ) to evaluate IFN-γ's role in mast cell development.
- In vivo assessment of peritoneal mast cell numbers in genetically modified mice.
Main Results:
- IFN-γ induced apoptosis in mast cells in a Stat1-dependent manner, involving mitochondrial dysfunction.
- Apoptosis was reduced in mast cells from p53- or Bax-deficient mice and H2K-Bcl-2 transgenic mice.
- SOCS-1 knockout mice exhibited significantly reduced mast cell numbers, an effect reversed by simultaneous IFN-γ deficiency, indicating a critical role for SOCS-1 in regulating IFN-γ's impact on mast cells.
Conclusions:
- IFN-γ potently regulates mast cell survival, inducing cell death both in vitro and in vivo.
- The study highlights the critical role of SOCS-1 in preventing IFN-γ-mediated mast cell loss, suggesting therapeutic targets for inflammatory diseases.